{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T12:33:23Z","timestamp":1787056403230,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T00:00:00Z","timestamp":1725235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T00:00:00Z","timestamp":1725235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-024-01683-5","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T03:16:18Z","timestamp":1725246978000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Stevens-Johnson Syndrome\/Toxic epidermal necrolysis complicated with fulminant type 1 diabetes mellitus: a case report and literature review"],"prefix":"10.1186","volume":"24","author":[{"given":"Xiaofang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dihua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dajun","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuwei","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangfeng","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,2]]},"reference":[{"key":"1683_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","volume":"129","author":"S Bastuji-Garin","year":"1993","unstructured":"Bastuji-Garin S, Rzany B, Stern RS, et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and Erythema Multiforme. Arch Dermatol. 1993;129:92\u20136.","journal-title":"Arch Dermatol"},{"key":"1683_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jdermsci.2020.02.003","volume":"98","author":"WC Chang","year":"2020","unstructured":"Chang WC, Abe R, Anderson P, et al. SJS\/TEN 2019: from science to translation. J Dermatol Sci. 2020;98:2\u201312.","journal-title":"J Dermatol Sci"},{"key":"1683_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/sj.jid.5701033","volume":"128","author":"M Mockenhaupt","year":"2008","unstructured":"Mockenhaupt M, Viboud C, Dunant A, et al. Toxic epidermal necrolysis: Assessment of Medication risks with emphasis on recently marketed drugs. The EuroSCAR-Study. J Invest Dermatol. 2008;128:35\u201344.","journal-title":"J Invest Dermatol"},{"key":"1683_CR4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1056\/NEJM200002033420501","volume":"342","author":"A Imagawa","year":"2000","unstructured":"Imagawa A, Hanafusa T, Miyagawa J, et al. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. N Engl J Med. 2000;342:301\u20137.","journal-title":"N Engl J Med"},{"key":"1683_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/ncpendmet0351","volume":"3","author":"T Hanafusa","year":"2007","unstructured":"Hanafusa T, Imagawa A. Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners. Nat Clin Pract Endocrinol Metab. 2007;3:36\u201345.","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"1683_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/jdi.13638","volume":"13","author":"SO Song","year":"2022","unstructured":"Song SO, Yun JS, Ko SH, et al. Prevalence and clinical characteristics of fulminant type 1 diabetes mellitus in Korean adults: a multi-institutional joint research. J Diabetes Investig. 2022;13:47\u201353.","journal-title":"J Diabetes Investig"},{"key":"1683_CR7","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1111\/jdi.13091","volume":"10","author":"Y Hosokawa","year":"2019","unstructured":"Hosokawa Y, Hanafusa T, Imagawa A. Pathogenesis of fulminant type 1 diabetes: genes, viruses and the immune mechanism, and usefulness of patient-derived induced pluripotent stem cells for future research. J Diabetes Investig. 2019;10:1158\u201364.","journal-title":"J Diabetes Investig"},{"key":"1683_CR8","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3389\/fendo.2019.00474","volume":"10","author":"B Zhu","year":"2019","unstructured":"Zhu B, Wu J, Chen G, et al. Fulminant type 1 diabetes mellitus caused by drug reaction with eosinophilia and systemic symptoms (DRESS): a case report and review of the literature. Front Endocrinol. 2019;10:474.","journal-title":"Front Endocrinol"},{"key":"1683_CR9","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/ACI.0000000000000546","volume":"19","author":"MR Ardern-Jones","year":"2019","unstructured":"Ardern-Jones MR, Mockenhaupt M. Making a diagnosis in severe cutaneous drug hypersensitivity reactions. Curr Opin Allergy Clin Immunol. 2019;19:283\u201393.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"1683_CR10","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/j.jid.2016.03.023","volume":"136","author":"DY Hsu","year":"2016","unstructured":"Hsu DY, Brieva J, Silverberg NB, et al. Morbidity and mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis in United States adults. J Invest Dermatol. 2016;136:1387\u201397.","journal-title":"J Invest Dermatol"},{"key":"1683_CR11","doi-asserted-by":"publisher","first-page":"3840","DOI":"10.2174\/1381612825666191107162921","volume":"25","author":"H Guvenir","year":"2019","unstructured":"Guvenir H, Arikoglu T, Vezir E, et al. Clinical phenotypes of severe cutaneous drug hypersensitivity reactions. Curr Pharm Des. 2019;25:3840\u201354.","journal-title":"Curr Pharm Des"},{"key":"1683_CR12","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1056\/NEJM197005142822011","volume":"282","author":"KA Arndt","year":"1970","unstructured":"Arndt KA, Feingold DS. The sign of Pyotr Vasilyewich Nikolsky. N Engl J Med. 1970;282:1154\u20135.","journal-title":"N Engl J Med"},{"key":"1683_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s12016-017-8654-z","volume":"54","author":"M Lerch","year":"2018","unstructured":"Lerch M, Mainetti C, Terziroli Beretta-Piccoli B, et al. Current perspectives on Stevens-Johnson syndrome and toxic epidermal necrolysis. Clin Rev Allergy Immunol. 2018;54:147\u201376.","journal-title":"Clin Rev Allergy Immunol"},{"key":"1683_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2165\/11593240-000000000-00000","volume":"13","author":"N Mittmann","year":"2012","unstructured":"Mittmann N, Knowles SR, Koo M, et al. Incidence of toxic epidermal necrolysis and Stevens-Johnson syndrome in an HIV cohort: an observational, retrospective case series study. Am J Clin Dermatol. 2012;13:49\u201354.","journal-title":"Am J Clin Dermatol"},{"key":"1683_CR15","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1177\/0310057X0703500317","volume":"35","author":"JM Mulvey","year":"2007","unstructured":"Mulvey JM, Padowitz A, Lindley-Jones M, et al. Mycoplasma pneumoniae associated with Stevens Johnson syndrome. Anaesth Intensive Care. 2007;35:414\u20137.","journal-title":"Anaesth Intensive Care"},{"key":"1683_CR16","doi-asserted-by":"publisher","first-page":"e183","DOI":"10.1111\/ijd.14811","volume":"59","author":"NJ Maloney","year":"2020","unstructured":"Maloney NJ, Ravi V, Cheng K, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis-like reactions to checkpoint inhibitors: a systematic review. Int J Dermatol. 2020;59:e183\u20138.","journal-title":"Int J Dermatol"},{"key":"1683_CR17","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1016\/j.burns.2023.08.003","volume":"49","author":"Y Gu","year":"2023","unstructured":"Gu Y, Sebaratnam DF. Contextualising associations of SJS\/TEN with COVID-19 and the vaccine. Burns. 2023;49:1776\u20137.","journal-title":"Burns"},{"key":"1683_CR18","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1046\/j.1365-2249.2000.01119.x","volume":"119","author":"L Le Cleach","year":"2000","unstructured":"Le Cleach L, Delaire S, Boumsell L, et al. Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors. Clin Exp Immunol. 2000;119:225\u201330.","journal-title":"Clin Exp Immunol"},{"key":"1683_CR19","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/jdi.12024","volume":"3","author":"A Imagawa","year":"2012","unstructured":"Imagawa A, Hanafusa T, Awata T, et al. Report of the Committee of the Japan Diabetes Society on the research of fulminant and acute-onset type 1 diabetes mellitus: new diagnostic criteria of fulminant type 1 diabetes mellitus. J Diabetes Investig. 2012;3:536\u20139.","journal-title":"J Diabetes Investig"},{"key":"1683_CR20","doi-asserted-by":"publisher","first-page":"E2277","DOI":"10.1210\/jc.2012-2054","volume":"97","author":"H Onuma","year":"2012","unstructured":"Onuma H, Tohyama M, Imagawa A, et al. High frequency of HLA B62 in fulminant type 1 diabetes with the drug-induced hypersensitivity syndrome. J Clin Endocrinol Metab. 2012;97:E2277\u201381.","journal-title":"J Clin Endocrinol Metab"},{"key":"1683_CR21","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/1346-8138.12770","volume":"4","author":"Y Kano","year":"2015","unstructured":"Kano Y, Tohyama M, Aihara M, et al. Sequelae in 145 patients with drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms: Survey conducted by the Asian Research Committee on severe cutaneous adverse reactions (ASCAR). J Dermatol. 2015;4:276\u201382.","journal-title":"J Dermatol"},{"key":"1683_CR22","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"S Elmore","year":"2007","unstructured":"Elmore S, Apoptosis. A review of programmed cell death. Toxicol Pathol. 2007;35:495\u2013516.","journal-title":"Toxicol Pathol"},{"issue":"2 Suppl","key":"1683_CR23","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1016\/j.jaad.2005.03.057","volume":"54","author":"CC Chiou","year":"2006","unstructured":"Chiou CC, Chung WH, Hung SI, et al. Fulminant type 1 diabetes mellitus caused by drug hypersensitivity syndrome with human herpesvirus 6 infection. J Am Acad Dermatol. 2006;54(2 Suppl):S14\u20137.","journal-title":"J Am Acad Dermatol"},{"key":"1683_CR24","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s12325-017-0530-y","volume":"34","author":"JA Schneider","year":"2017","unstructured":"Schneider JA, Cohen PR. Stevens-Johnson syndrome and toxic epidermal necrolysis: a concise review with a Comprehensive Summary of therapeutic interventions emphasizing supportive measures. Adv Ther. 2017;34:1235\u201344.","journal-title":"Adv Ther"},{"key":"1683_CR25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/MD.0b013e3181ca4290","volume":"89","author":"N de Prost","year":"2010","unstructured":"de Prost N, Ingen-Housz-Oro S, Duong T, et al. Bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis: Epidemiology, risk factors, and predictive value of skin cultures. Med (Baltim). 2010;89:28\u201336.","journal-title":"Med (Baltim)"},{"key":"1683_CR26","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1001\/jamadermatol.2016.5668","volume":"153","author":"S Zimmermann","year":"2017","unstructured":"Zimmermann S, Sekula P, Venhoff M, et al. Systemic immunomodulating therapies for Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and Meta-analysis. JAMA Dermatol. 2017;153:514\u201322.","journal-title":"JAMA Dermatol"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-024-01683-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-024-01683-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-024-01683-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T15:04:11Z","timestamp":1725289451000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-024-01683-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,2]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1683"],"URL":"https:\/\/doi.org\/10.1186\/s12902-024-01683-5","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,2]]},"assertion":[{"value":"15 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were carried out in accordance with relevant guidelines and regulations. The patient provided written informed consent for data collection. The study was approved by the ethics committee of Shaoxing People\u2019s Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent has been obtained from the patient for publication of this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"172"}}